tradingkey.logo


tradingkey.logo


Bio Rad Laboratories Inc

BIO
276.530USD
+2.930+1.07%
終倀 03/26, 16:00ET15分遅れの株䟡
7.81B時䟡総額
9.92盎近12ヶ月PER


Bio Rad Laboratories Inc

276.530
+2.930+1.07%

詳现情報 Bio Rad Laboratories Inc 䌁業名

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Bio Rad Laboratories Incの䌁業情報


䌁業コヌドBIO
䌚瀟名Bio Rad Laboratories Inc
䞊堎日Mar 17, 1980
最高経営責任者「CEO」Schwartz (Norman D)
埓業員数7700
蚌刞皮類Ordinary Share
決算期末Mar 17
本瀟所圚地1000 Alfred Nobel Dr
郜垂HERCULES
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United States of America
郵䟿番号94547
電話番号15107247000
りェブサむトhttps://www.bio-rad.com/
䌁業コヌドBIO
䞊堎日Mar 17, 1980
最高経営責任者「CEO」Schwartz (Norman D)

Bio Rad Laboratories Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+68.24%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.48%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+35.01%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+82.48%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+38.12%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+80.56%
Mr. Jeffrey L. (Jeff) Edwards
Mr. Jeffrey L. (Jeff) Edwards
Independent Director
Independent Director
308.00
--
Mr. Arnold A. Pinkston
Mr. Arnold A. Pinkston
Independent Director
Independent Director
308.00
--
Ms. Melinda Litherland
Ms. Melinda Litherland
Independent Director
Independent Director
--
--
Mr. Edward Chung
Mr. Edward Chung
Vice President - Investor Relations
Vice President - Investor Relations
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Norman D. Schwartz
Mr. Norman D. Schwartz
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.39M
+68.24%
Ms. Colleen Corey
Ms. Colleen Corey
Executive Vice President, Global Human Resources
Executive Vice President, Global Human Resources
19.55K
+5.48%
Mr. Sedat Evran
Mr. Sedat Evran
Executive Vice President - Global Supply Chain
Executive Vice President - Global Supply Chain
2.02K
+35.01%
Ms. Eva Anette Engelhardt
Ms. Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group
Executive Vice President, President of Clinical Diagnostics Group
896.00
+82.48%
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Lead Independent Director
Lead Independent Director
808.00
+38.12%
Ms. Courtney C Enloe
Ms. Courtney C Enloe
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
612.00
+80.56%

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
United States
270.00M
41.35%
EMEA
222.20M
34.03%
APAC
121.00M
18.53%
Other
39.80M
6.09%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Wed, Mar 18
曎新時刻: Wed, Mar 18
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
First Eagle Investment Management, L.L.C.
11.72%
Alice N. Schwartz Revocable Trust
8.13%
The Vanguard Group, Inc.
8.07%
BlackRock Institutional Trust Company, N.A.
6.66%
Schwartz (Norman D)
6.30%
他の
59.12%
株䞻統蚈
株䞻統蚈
比率
First Eagle Investment Management, L.L.C.
11.72%
Alice N. Schwartz Revocable Trust
8.13%
The Vanguard Group, Inc.
8.07%
BlackRock Institutional Trust Company, N.A.
6.66%
Schwartz (Norman D)
6.30%
他の
59.12%
皮類
株䞻統蚈
比率
Investment Advisor/Hedge Fund
43.79%
Investment Advisor
38.13%
Individual Investor
8.24%
Corporation
8.13%
Hedge Fund
4.09%
Research Firm
1.79%
Pension Fund
1.07%
Bank and Trust
0.98%
Sovereign Wealth Fund
0.52%

機関投資家保有株


曎新時刻: Mon, Dec 8
曎新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
1040
20.58M
101.60%
-3.97K
2025Q3
1095
20.58M
103.17%
+603.60K
2025Q2
1114
19.81M
108.02%
-855.27K
2025Q1
1146
19.96M
99.31%
-2.83M
2024Q4
1140
19.39M
101.48%
-657.49K
2024Q3
1121
20.03M
101.42%
-386.71K
2024Q2
1139
20.32M
91.46%
+1.29M
2024Q1
1154
19.07M
91.02%
-2.25M
2023Q4
1187
19.09M
89.28%
-259.69K
2023Q3
1170
19.31M
88.28%
-552.69K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
First Eagle Investment Management, L.L.C.
2.52M
11.5%
+3.01K
+0.12%
Sep 30, 2025
Alice N. Schwartz Revocable Trust
1.78M
8.13%
--
--
Sep 25, 2025
The Vanguard Group, Inc.
1.79M
8.17%
-53.01K
-2.88%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.48M
6.77%
-61.47K
-3.98%
Sep 30, 2025
Schwartz (Norman D)
1.39M
6.36%
+951.36K
+214.86%
Sep 25, 2025
Dimensional Fund Advisors, L.P.
1.06M
4.85%
+63.37K
+6.34%
Sep 30, 2025
Ariel Investments, LLC
809.48K
3.7%
-9.14K
-1.12%
Sep 30, 2025
EARNEST Partners, LLC
609.28K
2.78%
+3.40K
+0.56%
Sep 30, 2025
State Street Investment Management (US)
571.60K
2.61%
-12.77K
-2.18%
Sep 30, 2025
Veritas Asset Management LLP
844.04K
3.85%
-19.10K
-2.21%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Parnassus Value Select ETF
3.94%
First Trust Indxx Medical Devices ETF
2.15%
ROBO Global Healthcare Technology & Innovation ETF
1.61%
Schwab Ariel Opportunities ETF
1.6%
First Trust Health Care Alphadex Fund
1.49%
FPA Global Equity ETF
1.38%
First Eagle Global Equity ETF
1.21%
iShares Health Innovation Active ETF
1.17%
Pacer US Export Leaders ETF
1.03%
Harbor Health Care ETF
0.82%
詳现を芋る
Parnassus Value Select ETF
比率3.94%
First Trust Indxx Medical Devices ETF
比率2.15%
ROBO Global Healthcare Technology & Innovation ETF
比率1.61%
Schwab Ariel Opportunities ETF
比率1.6%
First Trust Health Care Alphadex Fund
比率1.49%
FPA Global Equity ETF
比率1.38%
First Eagle Global Equity ETF
比率1.21%
iShares Health Innovation Active ETF
比率1.17%
Pacer US Export Leaders ETF
比率1.03%
Harbor Health Care ETF
比率0.82%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™